Medical - Care Facilities
Compare Stocks
2 / 10Stock Comparison
ENSG vs SEM
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
ENSG vs SEM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Care Facilities | Medical - Care Facilities |
| Market Cap | $10.28B | $2.04B |
| Revenue (TTM) | $5.27B | $5.52B |
| Net Income (TTM) | $363M | $134M |
| Gross Margin | 15.2% | 10.6% |
| Operating Margin | 8.5% | 5.8% |
| Forward P/E | 23.4x | 13.1x |
| Total Debt | $4.15B | $3.70B |
| Cash & Equiv. | $504M | $27M |
ENSG vs SEM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| The Ensign Group, I… (ENSG) | 100 | 402.4 | +302.4% |
| Select Medical Hold… (SEM) | 100 | 188.8 | +88.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ENSG vs SEM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ENSG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 12 yrs, beta 0.42, yield 0.1%
- Rev growth 18.7%, EPS growth 14.1%, 3Y rev CAGR 18.7%
- 7.6% 10Y total return vs SEM's 151.9%
SEM is the clearest fit if your priority is value.
- Lower P/E (13.1x vs 23.4x)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.7% revenue growth vs SEM's 5.1% | |
| Value | Lower P/E (13.1x vs 23.4x) | |
| Quality / Margins | 6.9% margin vs SEM's 2.4% | |
| Stability / Safety | Beta 0.42 vs SEM's 0.46 | |
| Dividends | 0.1% yield, 12-year raise streak, vs SEM's 1.5% | |
| Momentum (1Y) | +33.7% vs SEM's +13.1% | |
| Efficiency (ROA) | 6.8% ROA vs SEM's 2.3%, ROIC 7.0% vs 4.8% |
ENSG vs SEM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
ENSG vs SEM — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ENSG leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
SEM and ENSG operate at a comparable scale, with $5.5B and $5.3B in trailing revenue. Profitability is closely matched — net margins range from 6.9% (ENSG) to 2.4% (SEM). On growth, ENSG holds the edge at +18.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $5.3B | $5.5B |
| EBITDAEarnings before interest/tax | $558M | $465M |
| Net IncomeAfter-tax profit | $363M | $134M |
| Free Cash FlowCash after capex | $406M | $117M |
| Gross MarginGross profit ÷ Revenue | +15.2% | +10.6% |
| Operating MarginEBIT ÷ Revenue | +8.5% | +5.8% |
| Net MarginNet income ÷ Revenue | +6.9% | +2.4% |
| FCF MarginFCF ÷ Revenue | +7.7% | +2.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +18.4% | +5.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +21.9% | -18.2% |
Valuation Metrics
SEM leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 13.9x trailing earnings, SEM trades at a 54% valuation discount to ENSG's 30.1x P/E. On an enterprise value basis, SEM's 12.0x EV/EBITDA is more attractive than ENSG's 25.9x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $10.3B | $2.0B |
| Enterprise ValueMkt cap + debt − cash | $13.9B | $5.7B |
| Trailing P/EPrice ÷ TTM EPS | 30.13x | 13.93x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.41x | 13.06x |
| PEG RatioP/E ÷ EPS growth rate | 2.18x | — |
| EV / EBITDAEnterprise value multiple | 25.88x | 12.04x |
| Price / SalesMarket cap ÷ Revenue | 2.03x | 0.37x |
| Price / BookPrice ÷ Book value/share | 4.64x | 1.00x |
| Price / FCFMarket cap ÷ FCF | 27.72x | 5.33x |
Profitability & Efficiency
ENSG leads this category, winning 6 of 8 comparable metrics.
Profitability & Efficiency
ENSG delivers a 16.6% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $7 for SEM. SEM carries lower financial leverage with a 1.82x debt-to-equity ratio, signaling a more conservative balance sheet compared to ENSG's 1.86x.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +16.6% | +6.6% |
| ROA (TTM)Return on assets | +6.8% | +2.3% |
| ROICReturn on invested capital | +7.0% | +4.8% |
| ROCEReturn on capital employed | +10.2% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 1.86x | 1.82x |
| Net DebtTotal debt minus cash | $3.7B | $3.7B |
| Cash & Equiv.Liquid assets | $504M | $27M |
| Total DebtShort + long-term debt | $4.2B | $3.7B |
| Interest CoverageEBIT ÷ Interest expense | 88.33x | 4.41x |
Total Returns (Dividends Reinvested)
ENSG leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ENSG five years ago would be worth $20,520 today (with dividends reinvested), compared to $8,660 for SEM. Over the past 12 months, ENSG leads with a +33.7% total return vs SEM's +13.1%. The 3-year compound annual growth rate (CAGR) favors ENSG at 24.1% vs SEM's 1.3% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +1.2% | +11.4% |
| 1-Year ReturnPast 12 months | +33.7% | +13.1% |
| 3-Year ReturnCumulative with dividends | +91.1% | +4.0% |
| 5-Year ReturnCumulative with dividends | +105.2% | -13.4% |
| 10-Year ReturnCumulative with dividends | +760.4% | +151.9% |
| CAGR (3Y)Annualised 3-year return | +24.1% | +1.3% |
Risk & Volatility
Evenly matched — ENSG and SEM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ENSG is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SEM's 0.46 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. SEM currently trades 96.8% from its 52-week high vs ENSG's 80.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.42x | 0.46x |
| 52-Week HighHighest price in past year | $218.00 | $16.99 |
| 52-Week LowLowest price in past year | $129.91 | $11.65 |
| % of 52W HighCurrent price vs 52-week peak | +80.7% | +96.8% |
| RSI (14)Momentum oscillator 0–100 | 28.6 | 62.9 |
| Avg Volume (50D)Average daily shares traded | 348K | 2.1M |
Analyst Outlook
Evenly matched — ENSG and SEM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates ENSG as "Buy" and SEM as "Hold". Consensus price targets imply 26.4% upside for ENSG (target: $222) vs 9.5% for SEM (target: $18). For income investors, SEM offers the higher dividend yield at 1.55% vs ENSG's 0.14%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $222.33 | $18.00 |
| # AnalystsCovering analysts | 13 | 13 |
| Dividend YieldAnnual dividend ÷ price | +0.1% | +1.5% |
| Dividend StreakConsecutive years of raises | 12 | 0 |
| Dividend / ShareAnnual DPS | $0.24 | $0.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +4.9% |
ENSG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEM leads in 1 (Valuation Metrics). 2 tied.
ENSG vs SEM: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is ENSG or SEM a better buy right now?
For growth investors, The Ensign Group, Inc.
(ENSG) is the stronger pick with 18. 7% revenue growth year-over-year, versus 5. 1% for Select Medical Holdings Corporation (SEM). Select Medical Holdings Corporation (SEM) offers the better valuation at 13. 9x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate The Ensign Group, Inc. (ENSG) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ENSG or SEM?
On trailing P/E, Select Medical Holdings Corporation (SEM) is the cheapest at 13.
9x versus The Ensign Group, Inc. at 30. 1x. On forward P/E, Select Medical Holdings Corporation is actually cheaper at 13. 1x.
03Which is the better long-term investment — ENSG or SEM?
Over the past 5 years, The Ensign Group, Inc.
(ENSG) delivered a total return of +105. 2%, compared to -13. 4% for Select Medical Holdings Corporation (SEM). Over 10 years, the gap is even starker: ENSG returned +760. 4% versus SEM's +151. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ENSG or SEM?
By beta (market sensitivity over 5 years), The Ensign Group, Inc.
(ENSG) is the lower-risk stock at 0. 42β versus Select Medical Holdings Corporation's 0. 46β — meaning SEM is approximately 9% more volatile than ENSG relative to the S&P 500. On balance sheet safety, Select Medical Holdings Corporation (SEM) carries a lower debt/equity ratio of 182% versus 186% for The Ensign Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ENSG or SEM?
By revenue growth (latest reported year), The Ensign Group, Inc.
(ENSG) is pulling ahead at 18. 7% versus 5. 1% for Select Medical Holdings Corporation (SEM). On earnings-per-share growth, the picture is similar: The Ensign Group, Inc. grew EPS 14. 1% year-over-year, compared to -28. 9% for Select Medical Holdings Corporation. Over a 3-year CAGR, ENSG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ENSG or SEM?
The Ensign Group, Inc.
(ENSG) is the more profitable company, earning 6. 8% net margin versus 2. 7% for Select Medical Holdings Corporation — meaning it keeps 6. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ENSG leads at 8. 6% versus 6. 1% for SEM. At the gross margin level — before operating expenses — ENSG leads at 13. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ENSG or SEM more undervalued right now?
On forward earnings alone, Select Medical Holdings Corporation (SEM) trades at 13.
1x forward P/E versus 23. 4x for The Ensign Group, Inc. — 10. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ENSG: 26. 4% to $222. 33.
08Which pays a better dividend — ENSG or SEM?
All stocks in this comparison pay dividends.
Select Medical Holdings Corporation (SEM) offers the highest yield at 1. 5%, versus 0. 1% for The Ensign Group, Inc. (ENSG).
09Is ENSG or SEM better for a retirement portfolio?
For long-horizon retirement investors, Select Medical Holdings Corporation (SEM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
46), 1. 5% yield, +151. 9% 10Y return). Both have compounded well over 10 years (SEM: +151. 9%, ENSG: +760. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ENSG and SEM?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ENSG is a mid-cap high-growth stock; SEM is a small-cap deep-value stock. SEM pays a dividend while ENSG does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.